PT-141
$71.50Price
PT-141 (Bremelanotide) is a synthetic peptide that targets the central nervous system and melanocortin receptors (MC3/MC4) to stimulate sexual desire and arousal, differentiating it from vascular drugs like Viagra.
Key Research Areas
In Women: FDA-approved (as Vyleesi) to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
In Men: Studied off-label for erectile dysfunction (ED), particularly for patients unresponsive to PDE5 inhibitors.